ATE61057T1 - Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen. - Google Patents

Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen.

Info

Publication number
ATE61057T1
ATE61057T1 AT85108135T AT85108135T ATE61057T1 AT E61057 T1 ATE61057 T1 AT E61057T1 AT 85108135 T AT85108135 T AT 85108135T AT 85108135 T AT85108135 T AT 85108135T AT E61057 T1 ATE61057 T1 AT E61057T1
Authority
AT
Austria
Prior art keywords
carbapenems
2quaternal
pyridinium
alkylated
possessing
Prior art date
Application number
AT85108135T
Other languages
English (en)
Inventor
Burton G Christensen
Susan M Schmitt
David B R Johnston
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE61057T1 publication Critical patent/ATE61057T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT85108135T 1984-07-02 1985-07-01 Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen. ATE61057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62657984A 1984-07-02 1984-07-02
EP85108135A EP0167139B1 (de) 1984-07-02 1985-07-01 Carbapeneme die einen externen alkylierten 2-quaternären Pyridiniumalkylthio-Substituenten besitzen

Publications (1)

Publication Number Publication Date
ATE61057T1 true ATE61057T1 (de) 1991-03-15

Family

ID=24510989

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85108135T ATE61057T1 (de) 1984-07-02 1985-07-01 Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen.

Country Status (7)

Country Link
EP (1) EP0167139B1 (de)
JP (1) JPS6163678A (de)
AT (1) ATE61057T1 (de)
CA (1) CA1273011A (de)
DE (1) DE3581847D1 (de)
DK (1) DK297385A (de)
ES (1) ES8609337A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339860C (en) * 1985-06-17 1998-05-12 Tsunehiko Soga Derivatives of penem
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
US5242914A (en) * 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
DE68919508T2 (de) * 1988-04-01 1995-07-20 Sankyo Co 2-(Heterocyclylthio)carbapenemderivate, deren Herstellung und deren Verwendung als Antibiotika.
JP2752143B2 (ja) * 1988-04-01 1998-05-18 三共株式会社 カルバペネム誘導体
WO1991000864A1 (fr) * 1989-07-07 1991-01-24 Banyu Pharmaceutical Co., Ltd. Derives de carbapenemes
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
NO315930B1 (no) * 1995-01-18 2003-11-17 Picower Inst For Medical Res T Anvendelse av tiazoliumforbindelser ved fremstilling av farmasöytiske preparater, preparater som inneholder forbindelsene, samt nyetiazoliumforbindelser
US5656261A (en) 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
EP0808163B1 (de) * 1995-01-18 2003-07-23 Alteon, Inc. Verwendung von thiazoliumverbindungen zum verhindern und umkehren der bildung von endprodukten der fortgeschrittenen glykosylierung
DE19840943A1 (de) * 1998-09-08 2000-03-09 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von Derivaten des 4-Alkylsulfinylmethylarylenmethanols
US6121300A (en) 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US20050014747A1 (en) 2003-04-18 2005-01-20 Emily Reinhard Dihydrothiazine prodrugs of thiazolium agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR244550A1 (es) * 1978-07-24 1993-11-30 Merck & Co Inc Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
NZ201471A (en) * 1981-08-10 1985-09-13 Merck & Co Inc Antibacterial compositions containing penems and dipeptidase inhibitors
ZA836966B (en) * 1982-09-28 1984-04-25 Bristol Myers Co Carbapenem antibiotics
NZ205626A (en) * 1982-09-28 1986-12-05 Bristol Myers Co Carbapenem antibiotics

Also Published As

Publication number Publication date
DK297385D0 (da) 1985-07-01
EP0167139B1 (de) 1991-02-27
ES544752A0 (es) 1986-09-01
ES8609337A1 (es) 1986-09-01
JPS6163678A (ja) 1986-04-01
EP0167139A1 (de) 1986-01-08
DK297385A (da) 1986-03-14
DE3581847D1 (de) 1991-04-04
CA1273011A (en) 1990-08-21

Similar Documents

Publication Publication Date Title
DE3581847D1 (de) Carbapeneme die einen externen alkylierten 2-quaternaeren pyridiniumalkylthio-substituenten besitzen.
DE3776740D1 (de) Blindleistungskompensator.
DE3684631D1 (de) Direkt gesteuerte drehmaschine.
BR8700200A (pt) Conjunto fechador de porta
IN170909B (de)
DE3860818D1 (de) Drehtuer.
ES8609336A1 (es) Un procedimiento para la preparacion de -1-metilcarbapenems.
AU598728B2 (en) Antibacterial compounds, their production and use
FI865004A0 (fi) 5-amino- och 5-hydroxi-6,8 -difluorkinoloner saosom antibakteriska aemnen.
DE3761587D1 (de) Stufenlos blockierbare verstelleinrichtung.
IL118368A0 (en) N-oxide heteroaroyl derivatives
AU6307586A (en) Quinoline derivatives
DE3860977D1 (en) (1r,5s,6s)-2-(substituiertes thio)-6-((r)-1-hydroxy-aethyl)-1-methyl-carbapenem-3-carbonsaeurederivate.
NL192256B (nl) Verzonken schuifraamsamenstel.
DE3580183D1 (de) Antibakterielle chinobenzoxazin-verbindungen.
IE823087L (en) Azetidinones.
DK297485D0 (da) Carbapenemer med kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
FI860870L (fi) Antibakteriska foereningar, deras framstaellning och anvaendning.
FI861763A7 (fi) Karbapenemderivat.
ATE54151T1 (de) Erythromycylamin-derivate.
NO875125L (no) Elastisk pakning for doerer, vinduer o.l.
DE3779856D1 (de) Antibakterielle, 2-substituierte alkyl-carbapeneme.
ATE70841T1 (de) 2-(1-oxo-1-imino-1-thiacycloalkyl)-thiopenemderivate.
JPS57158754A (en) Improvement on organic compounds
KR880015122U (ko) 유압 도어 클로우져

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee